Share The implantable miniature telescope (IMT) has received final approval by the U.S. Food and Drug Administration. 

Smaller than a pea, the device is implanted in one eye for enhanced central vision.  The other eye is not touched and is used for peripheral vision.  The procedure is done on an outpatient basis and includes the removal of the natural lens of the eye. 

It will be available to those who are 75 years or older and have stable severe to profound vision loss. Individuals who have already had their cataract removed are NOT eligible for the implant.

VisionCare, the developer of the device, will monitor patients who receive the implant and those who received it in the clinical trial will also be followed for two years. 

As is standard for new devices, approval for payment is being sought from Medicare, but it is not currently covered. 

Information about the implant and treatment programs can be found at CentraSight. 

Remember that this device is not for everyone and does require training to make it useful.  Sometimes, external devices for low vision can be another answer - and they don't require surgery.